The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters

European Journal of Heart Failure

Volumn 7, Issue 2, 2005, Pages 199-203

  Kouris, Nikos T ^a   Zacharos, Ioannis D ^b   Kontogianni, Dimitra D ^a   Goranitou, Georgia S ^a   Sifaki, Maria D ^a   Grassos, Haris E ^a   Kalkandi, Eleni M ^a   Babalis, Dimitris K ^a  

^a Western Attica General Hospital   (Greece)

^b Social Security Institution   (Greece)

Author keywords

CA125; Congestive heart failure; Tumor marker

Indexed keywords

CA 125 ANTIGEN;

AGED; ANAMNESIS; ANKLE EDEMA; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DECELERATION; DIASTOLE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EMERGENCY WARD; ENZYME IMMUNOASSAY; EVALUATION; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE SIZE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMMUNORADIOMETRIC ASSAY; KIDNEY FUNCTION; LIVER FUNCTION; LUNG CONGESTION; LUNG FLUID; MALE; PRESCRIPTION; PRIORITY JOURNAL; SERUM; SYMPTOM; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; COHORT STUDIES; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR PRESSURE;

EID: 13444306581     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.07.015     Document Type: Article

References (25)

1. R.C. Bast Jr., T.L. Klug, E. St John, E. Jenison, J.M. Niloff, and H. Lazarus A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer N. Engl. J. Med. 309 1983 883 887
2. P.A. Canney, M. Moore, P.M. Wilkinson, and R.D. James Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumor marker Br. J. Cancer 50 1984 765 769
3. A. Camera, M.R. Villa, S. Rocco, T. De Novellis, S. Costantini, and L. Pezzullo Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement Cancer 88 2000 75 78
4. M. Ozguroglu, H. Turna, G. Demir, A. Doventas, F. Demirelli, and N.M. Mandel Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma Am. J. Clin. Oncol. 22 1999 615 618
5. M. Lazzarino, E. Orlandi, C. Klersy, C. Astori, E. Brusamolino, and A. Corso Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity Cancer 82 1998 576 582
6. I.D. Zacharos, S.P. Efstathiou, E. Petreli, G. Georgiou, D.I. Tsioulos, and S.E. Mastorantonakis The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma Eur. J. Haematol. 69 4 2002 (Oct.) 221 226
7. K. Sakamoto, Y. Haga, R. Yoshimura, H. Egami, Y. Yokoyama, and M. Akagi Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system Gut 28 1987 323 329
8. R. Klapdor, U. Klapdor, M. Bahlo, M. Dallek, B. Kremer, and H. van Ackeren CA 125 in carcinomas of the digestive tract Dtsch. Med. Wochenschr. 199 1984 1949 1954
9. J.F. Bergmann, J.M. Bidart, M. George, M. Beaugrand, V.G. Levy, and C. Bohuon Elevation of CA 125 in patients with benign and malignant ascites Cancer 59 1987 213 217
10. G.H. Eltabbakh, J.L. Belinson, A.W. Kennedy, M. Gupta, K. Webster, and L.E. Blumenson Serum CA-125 measurements >65 U/ml. Clinical value J. Reprod. Med. 42 1997 617 624
11. R.W. Talbot, D.J. Jacobsen, D.M. Nagorney, G.D. Malkasian, and RE Ritts Jr. Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer Surg. Gynecol. Obstet. 168 1989 407 412
12. R. Molina, X. Filella, J. Bruix, P. Mengual, J. Bosch, and X. Calvet Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases Clin. Chem. 37 1991 1379 1383
13. H. Halila, U.H. Stenman, and M. Seppala Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy Cancer 57 1986 1327 1329
14. R.L. Barbieri, J.M. Niloff, R.C. Bast, R.N. Schaetzi, R.W. Kirstner, and R.C. Knapp Elevated serum concentrations of CA 125 in patients with advanced endometriosis Fertil. Steril. 45 1986 630 634
15. S.A. Candocia, and G.Y. Locker Elevated serum CA 125 secondary to tuberculous peritonitis Cancer 72 1993 2016 2018
16. K. Okazaki, K. Mizuno, K. Katoh, S. Hashomoto, and S. Fukuchi Tuberculous peritonitis with extraordinarily high serum CA 125 J. Med. 23 1992 353 361
17. T. Seo, Y. Ikeda, H. Onaka, T. Hayashi, K. Kawaguchi, and C. Kotake Usefulness of serum CA125 measurement for monitoring pericardial effusion Jpn. Circ. J. 57 6 1993 (Jun) 489 494
18. H. Nagele, M. Bahlo, R. Klapdor, D. Schaeperkoetter, and W. Rodiger CA125 and its relation to cardiac function Am. Heart J. 137 6 1999 (Jun.) 1044 1049
19. SPSS Statistical Package for the Social Sciences. Windows Version, Release 10.0 2000 SPSS Chicago
20. R.L. Apel, and B.J. Fernandes Malignant lymphoma presenting with an elevated serum CA-125 level Arch. Pathol. Lab. Med. 119 1995 373 376
21. A. Camera, M.R. Villa, S. Rocco, T. De Novellis, S. Costantini, and L. Pezzullo Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement Cancer 88 2000 75 78
22. G.A. MacGowan, D.L. Mann, R.L. Kormos, A.M. Feldman, and S. Murali Circulating interleukin-6 in severe heart failure Am. J. Cardiol. 79 8 1997 (Apr 15) 1128 1131
23. I. Kubonishi, K. Bandobashi, N. Murata, M. Daibata, E. Ido, and H. Sonobe High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma Br. J. Haematol. 98 2 1997 (Aug.) 450 452
24. C. Duman, E. Ercan, I. Tengiz, H. Bozdemir, H.E. Ercan, and I. Nalbantgil Elevated serum CA 125 levels in mitral stenotic patients with heart failure Cardiology 100 1 2003 7 10
25. A. D'Aloia, P. Faggiano, G. Aurigemma, L. Bontempi, G. Ruggeri, and M. Metra Serum levels of cardohydrate antigen 125 in patients with chronic heart failure. Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities and short term prognosis J. Am. Coll. Cardiol. 41 2003 1805 1811